Detail

Study ID: NRG GY020

Title:

A Phase III Randomized Trial of Radiation +/- MK-3475 (Pembrolizumab) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer

Location:
Bismarck Region, Fargo Region, Sioux Falls Region
Principal Investigator:
Maria Bell, MD
Disease:
Endometrial
Stage:
Phase III
Status:
Active - Open to Accrual